Cite

HARVARD Citation

    Siglin, J. et al. (2020). C-reactive protein: not always a reliable marker of ongoing cytokine release syndrome in CAR-T therapy following IL-6 blockade. Leukemia & lymphoma. 61 (9), pp. 2280-2282. [Online]. 
  
Back to record